Gastroenterology and Pharmacotherapy

The medical management of patients with gastrointestinal diseases is advancing rapidly. Specific attention was given to the future prospects for medical management of 3 common gastrointestinal disease areas: antisecretory therapy, chronic hepatitis C, and inflammatory bowel disease. Newer strategies to eradicate hepatitis C virus infection using different interferons, such as interferon alfacon-1 or higher doses of peginterferon, or long-term maintenance peginterferon, are undergoing study and show promise based on data from preliminary studies. Several immunomodulators have promise in inflammatory bowel disease, although the risk-benefit ratio and costs of therapy require evaluation. Nevertheless, the success of new biologics such as anti-TNFα agents augurs well for effective future therapies.

    Related Conference of Gastroenterology and Pharmacotherapy

    October 16-18, 2017

    2nd World Summit on Metabolic Disorders

    Chicago, Illinois, USA
    December 07-08, 2017

    2nd International Conference on Digestive Diseases

    Madrid, Spain
    December 14-15, 2017

    11th World Gastroenterologists Summit

    Dubai, UAE
    March 15-16, 2018

    12th Global
    Gastroenterologists Meeting

    Barcelona, Spain
    April 09-10, 2018

    12th International Conference on Abdominal Imaging and Endoscopy

    Amsterdam, Netherlands
    April 09-11, 2018

    6th World Congress on Hepatitis & Liver Diseases

    Amsterdam, Netherlands
    May 28-29, 2018

    6th International Conference on Hepatology

    Osaka, Japan
    August 02-04, 2018

    13th Euro-Goblal Gastroenterology Conference

    Barcelona, Spain
    August 27-28, 2018
    10 Plenary Forums - 1Event

    Pancreas 2018

    Oct 22-23, 2018

    World Summit on Liver Cirrhosis and Hepatitis

    Osaka, Japan

    Gastroenterology and Pharmacotherapy Conference Speakers